AstraZeneca in $1.9 billion licensing deal with HK-listed CSPC - MarketScreener

Retrieved on: 2024-10-07 14:57:34

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca in $1.9 billion licensing deal with HK-listed CSPC - MarketScreener. View article details on hiswai:

Excerpt

AstraZeneca said on Monday it would pay up to $1.9 billion to CSPC Pharmaceutical Group Ltd in an exclusive license agreement to boost the ...

Article found on: www.marketscreener.com